论文部分内容阅读
丙型肝炎病毒(hepatitis C virus,HCV)感染可导致人类肝脏疾病,包括慢性丙型肝炎、肝硬化甚至迁延为肝细胞癌等。干扰素-α(interferon alpha,IFN-α)单独或联合利巴韦林以及HCV特异性NS3/4A、NS5B抑制剂是目前临床治疗慢性
Hepatitis C virus (HCV) infection can lead to human liver diseases, including chronic hepatitis C, cirrhosis and even to hepatocellular carcinoma. Interferon-alpha (IFN-alpha) alone or in combination with ribavirin and HCV-specific NS3 / 4A and NS5B inhibitors are currently clinically effective in treating chronic